feed,title,long_url,short_url
Benzinga,"Despite Durability Questions, BMO Upgraded This Natural-Killer Cell Therapy Oncology Stock",https://benzinga.com/general/biotech/22/07/28038689/despite-durability-questions-bmo-upgraded-this-natural-killer-cell-therapy-oncology-stock,https://bit.ly/3O1oxkc
